Literature DB >> 8661121

A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2-q23.3.

Y Arai1, F Hosoda, K Nakayama, M Ohki.   

Abstract

Human chromosome 11q22-q23 is a pathologically important region in which a high level of loss of heterozygosity has been reported for breast, ovary, cervical, colon, and lung carcinomas, malignant melanomas, and hematologic malignancies. This strongly indicates that one or more tumor suppressor genes reside within the deleted region. In this report, we report the development of a contig map that covers most of the deleted regions found in these malignancies. The map comprises a contig of 66 overlapping yeast artificial chromosomes (YACs) and spans a region of 17 Mb from the PGR gene at 11q22.2 to the MLL gene at q23.3. In the process of screening the YACs, 50 new sequence-tagged site markers were developed from the termini of the YAC inserts. These markers were used for chromosome walking, and the data were then integrated into the contig map. NotI restriction mapping of these YACs revealed the presence of at least 26 NotI sites in the region. Using 22 of them, a NotI restriction map of the region from PGR to D11S939 was developed. This YAC contig will provide efficient tools for identification of the putative tumor suppressor gene(s).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661121     DOI: 10.1006/geno.1996.0339

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Clustered 11q23 and 22q11 breakpoints and 3:1 meiotic malsegregation in multiple unrelated t(11;22) families.

Authors:  T H Shaikh; M L Budarf; L Celle; E H Zackai; B S Emanuel
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Patient-specific probes for preimplantation genetic diagnosis of structural and numerical aberrations in interphase cells.

Authors:  H U Weier; S Munné; J Fung
Journal:  J Assist Reprod Genet       Date:  1999-04       Impact factor: 3.412

3.  Interleukin-1beta-converting enzyme (ICE) and related cell death genes ICErel-II and ICErel-III map to the same PAC clone at band 11q22.2-22.3.

Authors:  J Nasir; J L Theilmann; J P Vaillancourt; N A Munday; A Ali; S Scherer; B Beatty; D W Nicholson; M R Hayden
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

4.  Localization of Jacobsen syndrome breakpoints on a 40-Mb physical map of distal chromosome 11q.

Authors:  A Tunnacliffe; C Jones; D Le Paslier; R Todd; D Cherif; M Birdsall; L Devenish; C Yousry; F E Cotter; M R James
Journal:  Genome Res       Date:  1999-01       Impact factor: 9.043

5.  Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

Authors:  E K Goldberg; J M Glendening; Z Karanjawala; A Sridhar; G J Walker; N K Hayward; A J Rice; D Kurera; Y Tebha; J W Fountain
Journal:  Am J Hum Genet       Date:  2000-07-29       Impact factor: 11.025

6.  Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q.

Authors:  Y Murakami; T Nobukuni; K Tamura; T Maruyama; T Sekiya; Y Arai; H Gomyou; A Tanigami; M Ohki; D Cabin; P Frischmeyer; P Hunt; R H Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

7.  European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.

Authors:  V Launonen; K Laake; P Huusko; D Niederacher; M W Beckmann; R B Barkardottir; E K Geirsdottir; J Gudmundsson; P Rio; Y J Bignon; S Seitz; S Scherneck; I Bièche; M H Champème; D Birnbaum; G White; J Varley; M Sztán; E Olah; A Osorio; J Benitez; N Spurr; N Velikonja; B Peterlin; R Winqvist
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  A Japanese history of the Human Genome Project.

Authors:  Yoshiyuki Sakaki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.